Sector Experience
Healthcare
Experience
Roche
Other
Global Head, Development Science and Innovation
12/2015 - 1/2018
• Lead senior team of early clinical development expertise to design and execute, in collaboration with external partner, all as-pects of VAP-1 inhibitor program in osteoarthritis, including: clinical pharmacology (2 phase I trials, extensive PK/PD model-ing), CMC (scaleup, vendor management, synthesis optimization), preclinical toxicology (2 species, including extensive me-tabolite analysis), clinical development (2 phase IIa POC clinical trials), and global regulatory submissions.